Abstract: Provided herein are oral dosage forms comprising a) a core tablet comprising (i) a drug layer comprising apremilast and hypromellose acetate succinate (HPMCAS) in an amorphous solid dispersion; and (ii) a swellable layer comprising one or more swellable polymers; and b) a coating layer disposed on the core tablet, wherein the oral dosage form surface comprises at least one drug release orifice. The disclosed oral dosage forms provide once-a-day dosing of apremilast and are suitable for treating diseases or disorders ameliorated by inhibiting phosphodiesterase subtype IV (PDE4).

Abstract: A jewelry attachment device having a main body including a main platform that a person can rest their wrist or forearm thereon, and a clasp stand adjustably connected to the main body that includes a slot, such that a person can place a jewelry clasp member within the slot of the clasp stand in an opened position, place a jewelry item and their wrist or forearm upon the main platform, adjust the position of the clasp stand, and then connect with one hand a ring loop portion of the jewelry item to the jewelry clasp member.